Scotland backs two myeloma drugs turned down by NICE in EnglandA north-south divide threatens to emerge in multiple myeloma in the UK, after the Scottish Medicines Consortium (SMC) Share XScotland backs two myeloma drugs turned down by NICE in Englandhttps://pharmaphorum.com/news/scotland-backs-two-myeloma-drugs-tuned-down-by-nice-in-england/
Lilly pauses COVID-19 antibody trial after factory hits trouble with FDAEli Lilly has put a clinical trial of its COVID-19 antibody therapy on hold after FDA inspectors found Share XLilly pauses COVID-19 antibody trial after factory hits trouble with FDAhttps://pharmaphorum.com/news/lilly-pauses-covid-19-antibody-trial-after-factory-hits-trouble-with-fda/
Online male health clinic hires former NHSX director to guide medical strategyAn online health clinic for men, Numan, has completed a £10m series A funding round to expand business. Share XOnline male health clinic hires former NHSX director to guide medical strategyhttps://pharmaphorum.com/news/online-male-health-clinic-hires-former-nhsx-chief-to-guide-medical-strategy/
Record number of health firms feature in UK top 100 private tech listA record number of health and medtech companies have been included in the Sunday Times Sage Tech Track Share XRecord number of health firms feature in UK top 100 private tech listhttps://pharmaphorum.com/news/babylon-among/
J&J’s late-stage COVID-19 vaccine trial halted after ‘unexplained illness’Johnson & Johnson has paused further dosing in its COVID-19 vaccine clinical trial following an “unexplained illness” in Share XJ&J’s late-stage COVID-19 vaccine trial halted after ‘unexplained illness’https://pharmaphorum.com/news/jjs-late-stage-covid-19-vaccine-trial-halted-after-unexplained-illness/
Chord gets $16m to challenge Alexion with oral NMOSD drugSwiss biotech Chord Therapeutics has come out of stealth mode with a $16 million first-round financing that will Share XChord gets $16m to challenge Alexion with oral NMOSD drughttps://pharmaphorum.com/news/chord-gets-16m-to-challenge-alexion-with-oral-nmosd-drug/
New CEO Mortazavi takes UK biotech e-therapeutics into gene silencingUK biotech e-therapeutics has a new CEO, with executive chairman and former Silence Therapeutics chief Ali Mortazavi chosen Share XNew CEO Mortazavi takes UK biotech e-therapeutics into gene silencinghttps://pharmaphorum.com/news/new-ceo-mortazavi-takes-e-therapeutics-into-gene-silencing/
Scotland backs Merck/Pfizer’s Bavencio combo for kidney cancerThe Scottish Medicines Consortium (SMC) backed NHS use of nine new medicines at its meeting this week, including Share XScotland backs Merck/Pfizer’s Bavencio combo for kidney cancerhttps://pharmaphorum.com/news/scotland-backs-merck-pfizers-bavencio-combo-for-kidney-cancer/
UK biotech sector sets new record with more than £1bn investment in Q3There has been a well-publicised boom in biotech investment during the pandemic, and the UK is no exception, Share XUK biotech sector sets new record with more than £1bn investment in Q3https://pharmaphorum.com/news/uk-biotech-sector-sets-new-record-with-more-than-1bn-investment-in-q3/
